The Journal of Immunology · 2011 · 72 citations · 23 references
Life SciencesCell BiologyImmunologyCellular ImmunologyImmunoregulationInnate ImmunityDendritic Cell BiologyDendritic Cell RegulationImmune RegulationRegulatory T CellsT Cell ActivationT Cell BiologyCd4 Positive T CellsCytokine Expression RegulationDendritic Cell Tolerogenic FunctionDendritic Cell-mediated T Cell ActivationDendritic Cell-t Cell InteractionProinflammatory Cytokine ModulationProinflammatory MediatorsRegulatory T Cell Induction By Dendritic Cells
Dendritic cells (DCs) competent to express the regulatory enzyme IDO in mice are a small but distinctive subset of DCs. Previously, we reported that a high-dose systemic CpG treatment to ligate TLR9 in vivo induced functional IDO exclusively in splenic CD19(+) DCs, which stimulated resting Foxp3-lineage regulatory T cells (Tregs) to rapidly acquire potent suppressor activity. In this paper, we show that IDO was induced in spleen and peripheral lymph nodes after CpG treatment in a dose-dependent manner. Induced IDO suppressed local T cell responses to exogenous Ags and inhibited proinflammatory cytokine expression in response to TLR9 ligation. IDO induction did not occur in T cell-deficient mice or in mice with defective B7 or programmed death (PD)-1 costimulatory pathways. Consistent with these findings, CTLA4 or PD-1/PD-ligand costimulatory blockade abrogated IDO induction and prevented Treg activation via IDO following high-dose CpG treatment. Consequently, CD4(+)CD25(+) T cells uniformly expressed IL-17 shortly after TLR9 ligation. These data support the hypothesis that constitutive interactions from activated T cells or Tregs and IDO-competent DCs via concomitant CTLA4→B7 and PD-1→PD-ligand signals maintain the default potential to regulate T cell responsiveness via IDO. Acute disruption of these nonredundant interactions abrogated regulation via IDO, providing novel perspectives on the proinflammatory effects of costimulatory blockade therapies. Moreover, interactions between IDO-competent DCs and activated T cells in lymphoid tissues may attenuate proinflammatory responses to adjuvants such as TLR ligands.
23
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Jason D. Fontenot, Jeffrey P. Rasmussen, Marc A. Gavin et al. · Nature Immunology · 2005 · 1.8K citations
Modulation of tryptophan catabolism by regulatory T cells
Francesca Fallarino, Ursula Grohmann, Kwang Woo Hwang et al. · Nature Immunology · 2003 · 1.3K citations